Alexandre L’Heureux is the President and Chief Executive Officer of the Corporation. Mr. L’Heureux joined the Corporation as Chief Financial Officer in July 2010, and held this role until transitioning to the role of President and CEO in October 2016. Before joining WSP, from 2005 to 2010, Mr. L’Heureux was a Partner and Chief Financial Officer at Auven Therapeutics L.L.L.P. (formerly Celtic Therapeutics L.L.P.) and a Partner at Celtic Pharma Management L.P. Prior to that, he developed extensive knowledge of the alternative investments industry as the Vice President of Operations at Citibank - Hedge Fund Services (formerly BISYS Hedge Fund Services). He is a member of the Canadian Institute of Chartered Accountants and of the Chartered Financial Analysts Institute. Mr. L’Heureux was also appointed Fellow of the Ordre des comptables professionnels agréés du Québec (Quebec CPA Order) in 2017.